IRIS
CINELLI, ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 651
EU - Europa 227
AS - Asia 211
AF - Africa 7
OC - Oceania 2
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.101
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 647
SG - Singapore 149
IT - Italia 98
NL - Olanda 56
CN - Cina 28
IN - India 21
UA - Ucraina 16
DE - Germania 14
SE - Svezia 10
BG - Bulgaria 9
GB - Regno Unito 8
CI - Costa d'Avorio 7
IE - Irlanda 5
FR - Francia 4
ES - Italia 3
JP - Giappone 3
KR - Corea 3
AU - Australia 2
CL - Cile 2
MX - Messico 2
PL - Polonia 2
TH - Thailandia 2
TR - Turchia 2
VN - Vietnam 2
CA - Canada 1
EU - Europa 1
FI - Finlandia 1
HU - Ungheria 1
ID - Indonesia 1
KN - Saint Kitts e Nevis 1
Totale 1.101
Salva come PNG Salva come JPEG
Città #
Singapore 127
Chandler 117
Amsterdam 56
Napoli 52
Lawrence 44
Millbury 43
Ashburn 42
Des Moines 36
Santa Clara 34
Boston 28
Wilmington 19
Beijing 11
Fairfield 9
Naples 9
Houston 8
Sofia 7
Redwood City 6
Washington 6
Woodbridge 6
Bhubaneswar 5
Seattle 5
Asciano 4
Dublin 3
Esslingen am Neckar 3
Fremont 3
Gangnam-gu 3
Hyderabad 3
Los Angeles 3
Pune 3
Segrate 3
Burgas 2
Cambridge 2
Dallas 2
Hanoi 2
Hebei 2
Izmir 2
Magenta 2
Menlo Park 2
Mountain View 2
Nanjing 2
Puebla City 2
Redmond 2
Santiago 2
Stockholm 2
Studzianki 2
Tokyo 2
Véry 2
Ann Arbor 1
Arzano 1
Belpasso 1
Brescia 1
Budapest 1
Catania 1
Chengdu 1
Denver 1
Duncan 1
Ferrol 1
Folignano 1
Frankfurt am Main 1
Guangzhou 1
Gunzenhausen 1
Harbin 1
Horley 1
Hutchinson 1
Jakarta 1
Jinan 1
Kagoya 1
Kronberg 1
Kumar 1
Las Palmas 1
Latina 1
Melbourne 1
Munich 1
Mussidan 1
Nanning 1
Nola 1
Norwalk 1
Nuremberg 1
Ottawa 1
Palma 1
Paris 1
Philadelphia 1
Quartu Sant'elena 1
Recanati 1
San Jose 1
Shenyang 1
Shenzhen 1
Sydney 1
Wuhan 1
Xi'an 1
Totale 775
Salva come PNG Salva come JPEG
Nome #
Apremilast efficacy and safety in elderly psoriasis patients over a 48-weeks period 57
Efficacy and safety of risankizumab in psoriasis patients who failed anti‐IL‐17, anti‐12/23 and/or anti IL‐23: preliminary data of a real‐life 16‐week retrospective study 50
Erythrasmoid pityriasis versicolor with exclusive involvement of the pubis and inguinal region: report of two cases. 46
Erythrodermic psoriasis successfully and rapidly treated with brodalumab: report of two cases 45
A 15-year retrospective study on the prevalence of onychomycosis in psoriatic vs non-psoriatic patients: A new European shift from dermatophytes towards yeast. 41
A case of a primary cutaneous diffuse large B-cell lymphoma, leg type 41
Anti‐interleukin‐23 for psoriasis in elderly: guselkumab, risankizumab and tildrakizumab in real world practice 38
QuantiFERON TB‐gold conversion rate among psoriasis patients under biologics: a 9‐year retrospective study 37
Biologic Therapies, Psoriasis, and COVID-19: Our Experience at the Psoriasis Unit of the University of Naples Federico II 37
Efficacy and safety of ixekizumab in a group of 16 elderly patients with psoriasis over a 1‐year period 36
Calcipotriol/betamethasone dipropionate formulations for psoriasis: an overview of the options and efficacy data 33
Efficacy and safety of a new topical gel formulation containing retinol encapsulated in glycospheres and hydroxypinacolone retinoate, an antimicrobial peptide, salicylic acid, glycolic acid and niacinamide for the treatment of mild acne: preliminary results of a 2-month prospective study 33
Hereditary Angioedema Type III, Recurrent Pregnancy Loss and Heterozygous MTHFR Mutation 31
Risankizumab in real life: preliminary results of efficacy and safety in psoriasis during a 16-week period 31
Real life efficacy and safety of secukinumab in elderly psoriasis patients over a 2-year period 30
16-year real-life study on the prevalence of mycoses in a paediatric population 30
A case of Stewart-Treves Syndrome of the lower limbs: The usefulness of dermoscopy 28
Guselkumab in moderate to severe psoriasis in routine clinical care: an Italian 44-week real-life experience 27
A Case of Steatocystoma Multiplex in a Psoriatic Patient during Treatment with Anti-IL-12/23 27
Endocrinological disorders and inflammatory skin diseases during COVID-19 outbreak: A review of the literature 27
Dermoscopy and reflectance confocal microscopy of Kaposi's sarcoma: an overview 27
Occurrence of psoriasiform eruption during dupilumab therapy for adult atopic dermatitis: A case series 26
Tinea Capitis in Campania: A 5-Year Retrospective Study in Childhood and Adolescence (2013-2018). 24
Paracetamol-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient receiving apremilast therapy 23
Therapeutic update of biologics and small molecules for scalp psoriasis: a systematic review 23
Tildrakizumab: a new therapeutic option for erythrodermic psoriasis? 23
Teledermatology for patient management, dermatology education and research during the COVID-19 pandemic 22
Efficacy and safety of guselkumab in psoriasis patients who failed ustekinumab and/or anti IL-17: a real-life 52-week retrospective study 22
A case of erythrodermic psoriasis successfully treated with apremilast 22
Mycoses in the elderly population: what a 16-year experience has taught us 21
Chronic cutaneous ulcers management in dermatologic department during COVID-19 era 21
Leg paralysis after photodynamic therapy for Lymphomatoid Papulosis: a case report 19
Ocular Manifestations in Psoriasis Screening (OcMaPS) Questionnaire: A Useful Tool to Reveal Misdiagnosed Ocular Involvement in Psoriasis 18
Dietary Intervention: An Essential Part of the Management of Patients Affected by Hidradenitis Suppurativa 18
Real world practice indirect comparison between guselkumab and risankizumab: results from an Italian retrospective study 18
Safe distance, safe patients! Therapeutic management of oncological patients affected by cutaneous and mucosal adverse events during the COVID-19 pandemic: an Italian experience 16
Trends in epidemiology of melanoma in situ in a center of South-Italy: Data from a melanoma reference center during the period 2004–2018 16
Micro needling: A novel therapeutic approach for androgenetic alopecia, A Review of Literature 15
Retrospective analysis of skin toxicity in patients under anti-EGFR tyrosine kinase inhibitors: Our experience in lung cancer 15
Psoriasis awareness among general population: preliminary results of an online survey 14
Hedgehog inhibitors in the treatment of advanced basal cell carcinoma: risks and benefits 13
Real-world experience versus clinical trials: pros and cons in psoriasis therapy evaluation 13
Profile of baricitinib and its potential in the treatment of moderate to severe atopic dermatitis: A short review on the emerging clinical evidence 13
Treatment of pediatric psoriasis with TNF-antagonists: a real-life single-center case series 10
Guselkumab and risankizumab for psoriasis: a 44-week indirect real-life comparison 9
Ixekizumab in scalp psoriasis: Clinical, dermoscopical, and in vivo reflectance confocal microscopy evaluation 9
Totale 1.195
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.867
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.867
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202041 0 0 0 0 0 4 3 1 0 6 21 6
2020/2021182 2 11 1 11 29 13 5 57 4 28 18 3
2021/2022258 9 4 0 11 15 9 2 8 3 41 44 112
2022/2023301 46 30 12 11 34 31 0 18 37 55 22 5
2023/2024209 9 35 20 20 12 25 3 18 2 4 44 17
2024/2025192 55 84 3 5 45 0 0 0 0 0 0 0
Totale 1.195